Byrne AB, Arts P, Polyak SW, Feng J, Schreiber AW, Kassahn KS, et al. (2019). Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6. NPJ Genom Med.
Rius, R., Van Bergen, N.J., Compton, A.G., Riley, L.G., Kava, M.P., Balasubramaniam, S., et al. (2019). Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants. J Clin Med, 8(11).
Boughtwood T, for Australian Genomics (October 2019).
Prepared by Boughtwood T, Finlay K, on behalf of the National Clinical Genomic Consent Working Group, Australian Genomics. (December 2018). Updated 20 October 2019.
Haas M, Mattiske T, Boughtwood T, for Australian Genomics (October 2019).
Cheng, H., Capponi, S., Wakeling, E., Marchi, E., Li, Q., Zhao, M., et al. (2019). Hum Mutation.
Crellin, E., McClaren, B., Nisselle, A., Best, S., Gaff, C., & Metcalfe, S. (2019). Preparing Medical Specialists to Practice Genomic Medicine: Education an Essential Part of a Broader Strategy. Frontiers in Genetics, 10(789).
Mallett, A.J., Quinlan, C., Patel, C., Fowles, L., Crawford, J., Gattas, M., et al. (2019). Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation. Kidney Medicine.
Belcher A, Grewal N, Boughtwood T, Bunker D, Newson A & North K, on behalf of Australian Genomics. (2018)
Jayasinghe, K., White, S.M., Kerr, P.G., MacGregor, D., Stark, Z., Wilkins, E., et al. (2019). Isolated proteinuria due to CUBN homozygous mutation – challenging the investigative paradigm. BMC Nephrol, 20(1), 330.